Frontiers in Neuroscience (Oct 2024)
Corrigendum: Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial
- Michelle Rissling,
- Lianqi Liu,
- Shawn D. Youngstedt,
- Vera Trofimenko,
- Loki Natarajan,
- Loki Natarajan,
- Ariel B. Neikrug,
- Neelum Jeste,
- Barbara A. Parker,
- Barbara A. Parker,
- Sonia Ancoli-Israel,
- Sonia Ancoli-Israel
Affiliations
- Michelle Rissling
- Department of Psychiatry, University of California, San Diego, San Diego, CA, United States
- Lianqi Liu
- Department of Medicine, University of California, San Diego, San Diego, CA, United States
- Shawn D. Youngstedt
- Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, United States
- Vera Trofimenko
- St. Joseph Hospital, Orange, CA, United States
- Loki Natarajan
- Family Medicine and Public Health, University of California, San Diego, San Diego, CA, United States
- Loki Natarajan
- Moores Cancer Center, University of California, San Diego, San Diego, CA, United States
- Ariel B. Neikrug
- Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, United States
- Neelum Jeste
- Johnson & Johnson, San Diego, CA, United States
- Barbara A. Parker
- Department of Medicine, University of California, San Diego, San Diego, CA, United States
- Barbara A. Parker
- Moores Cancer Center, University of California, San Diego, San Diego, CA, United States
- Sonia Ancoli-Israel
- Department of Psychiatry, University of California, San Diego, San Diego, CA, United States
- Sonia Ancoli-Israel
- Moores Cancer Center, University of California, San Diego, San Diego, CA, United States
- DOI
- https://doi.org/10.3389/fnins.2024.1386314
- Journal volume & issue
-
Vol. 18
Abstract
No abstracts available.Keywords